Corruption, a lucrative business for the pharmaceutical industries.
By Gabriel Carrion Lopez
In August 2013, three months after Xi Jinping entered the Chinese government, a corruption scandal broke out in the national medical system, skilfully exercised by the multinational pharmaceutical companies based in that country. The campaign launched to settle responsibilities ended with the arrest of four senior officials of the British multinational GlaxoSmithKline (GSK) and the
https://bit.ly/41wcz8Y